Amneal Pharmaceuticals (AMRX) EBIT Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 4.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 40.17% |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | 60.25% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.25% |
| Dec 31, 2025 | -6.73% |
| Sep 30, 2025 | 16.62% |
| Jun 30, 2025 | 36.81% |
| Mar 31, 2025 | 901.16% |
| Dec 31, 2024 | 89.29% |
| Sep 30, 2024 | 46.04% |
| Jun 30, 2024 | 12.46% |
| Mar 31, 2024 | -30.73% |
| Dec 31, 2023 | -11.07% |
| Sep 30, 2023 | 214.36% |
| Jun 30, 2023 | 95.30% |
| Mar 31, 2023 | -15.84% |
| Dec 31, 2022 | 99.73% |
| Sep 30, 2022 | 33.79% |
| Jun 30, 2022 | -118.99% |
| Mar 31, 2022 | 26.01% |
| Dec 31, 2021 | -21.70% |
| Sep 30, 2021 | -27.41% |
| Jun 30, 2021 | 33.34% |